Статьи, помеченные тэгом ‘treatment of osteoporosis’

Amgen Inc. (NASDAQ: AMGN) earnings surpassed analysts’ expectations

Friday, July 30th, 2010

U.S. biotechnology company Amgen Inc. (NASDAQ: AMGN) has published data on the profit for the second quarter of 2010, surpassed expectations of analysts. It Amgen said that the launch of a new drug for the treatment of osteoporosis Prolia passes under the planned scheme.